All coronavirus articles – Page 2
-
CareersRemotely of value?
The benefits and drawbacks of working or studying from home are not clear cut
-
-
BusinessUS grants Pfizer’s Covid-19 vaccine full approval
WHO calls for delay to booster programmes to allow more global distribution
-
BusinessThe multi-pronged search for Covid-19 treatments
Drugs that block infection or reduce inflammation will complement vaccine protection
-
NewsPandemic continues to disrupt and depress UK researchers, survey finds
Researchers reported spending more time on peer-review activities, teaching and writing
-
BusinessDeveloping countries sidelined in Covid-19 vaccine scramble
Lack of funds and local manufacturing capacity has prevented Covax from competing with wealthier nations’ self-interest
-
OpinionMolly Shoichet: ‘We fail every day’
The Canadian biomedical engineer on failure, politics and celebrity science
-
NewsRace to understand Sars-CoV-2 variants amid fears virus might evade vaccines
Biochemical basis behind coronavirus variants’ success could hold key to defeating them
-
BusinessRegeneron’s Covid-19 antibodies help those who can’t make their own
Regn-Cov2 reduces deaths and shortens hospitalisation for these patients, even when given at late stages of infection
-
OpinionFurin fundamentals
There’s no direct evidence for the lab leak hypothesis – and the biochemistry of the virus might not tell us much about it
-
NewsHints that century-old TB vaccine offers an immune boost against Covid-19
Small study is part of global effort examining whether the BCG jab could help in the next pandemic
-
NewsUS onboard with effort to waive global Covid-19 vaccine patents
Biden administration says pandemic calls for ‘extraordinary measures’ to relinquish IP protections, but pharma and biotech sectors push back
-
OpinionHow the pandemic might change drug research
Derek Lowe muses on some positive lessons learned
-
BusinessWhy manufacturing Covid vaccines at scale is hard
Exploring the pinch points vaccine makers face as they ramp up production
-
NewsPractical chemistry classes resume at English universities
Lifting of lockdown restrictions allows students to return to teaching laboratories
-
BusinessCoronavirus variants stymie success of monoclonal antibodies
Lab-made antibodies can treat and protect people from Covid-19 but are more likely to succeed when administered as a cocktail
-
OpinionA rough guide to pharma partnership deals
Coronavirus vaccines are driving unusual collaborations with a range of benefits
-
BusinessCovid vaccination efforts bolstered by trial results from J&J and Novavax
A miserable January ended with positive news on the vaccine front but new variants added complications
-
OpinionObserving the state’s transition
Sweeping changes on both sides of the Atlantic have yet to deliver on their promises
-
OpinionBusiness as usual?
The pandemic has shown that we can react quickly to complex problems – can we do it to avert a climate crisis?